Novartis
$87.019876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$87.01
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.56 (-0.63%) Today
-$1.43 (-1.62%) As of 6:59 PM EDT after-hours
Why Robinhood?
You can buy or sell Novartis and other stocks, options, ETFs, and crypto commission-free!
About NVS
Novartis AG, also called Novartis, is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following four segments: Innovative Medicines, Alcon, Sandoz, and Corporate. Read More The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Alcon segment researches, develops, manufactures, distributes and sells eye care devices and vision care. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Employees
125,161
Headquarters
Basel, Basel-Stadt (Basle Town)
Founded
1996
Market Cap
202.34B
Price-Earnings Ratio
17.91
Dividend Yield
2.15
Average Volume
1.63M
High Today
$89.92
Low Today
$88.21
Open Price
$89.50
Volume
2.12M
52 Week High
$96.31
52 Week Low
$74.97
Collections
NVS News
Price Paid on Robinhood
6% Higher
Right Now
52 Week Low
$72.30
Average Price Paid
$81.77
52 Week High
$96.31
Analyst Ratings
56%
of 25 ratings
Buy
56%
Hold
28%
Sell
16%
NVS Earnings
$1.20
$1.25
$1.29
$1.34
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Oct 22, Pre-Market
